Literature DB >> 11150363

Brain tumors.

L M DeAngelis1.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11150363     DOI： 10.1056/NEJM200101113440207

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  505 in total

1.  Phase 0 and window of opportunity clinical trial design in neuro-oncology: a RANO review.

Authors:  Michael A Vogelbaum; Daria Krivosheya; Hamid Borghei-Razavi; Nader Sanai; Michael Weller; Wolfgang Wick; Riccardo Soffietti; David A Reardon; Manish K Aghi; Evanthia Galanis; Patrick Y Wen; Martin van den Bent; Susan Chang
Journal:  Neuro Oncol       Date:  2020-11-26       Impact factor: 12.300

2.  The patients' view: impact of the extent of resection, intraoperative imaging, and awake surgery on health-related quality of life in high-grade glioma patients-results of a multicenter cross-sectional study.

Authors:  Katrin Nickel; Mirjam Renovanz; Jochem König; Linda Stöckelmaier; Anne-Katrin Hickmann; Minou Nadji-Ohl; Jens Engelke; Elke Weimann; Dirk Freudenstein; Oliver Ganslandt; Lars Bullinger; Christian Rainer Wirtz; Jan Coburger
Journal:  Neurosurg Rev       Date:  2017-03-06       Impact factor: 3.042

3.  Comparison of F-18 FET-PET with F-18 FDG-PET for biopsy planning of non-contrast-enhancing gliomas.

Authors:  Michail Plotkin; C Blechschmidt; G Auf; F Nyuyki; L Geworski; T Denecke; W Brenner; F Stockhammer
Journal:  Eur Radiol       Date:  2010-06-03       Impact factor: 5.315

4.  Generation of polyclonal CMV-specific T cells for the adoptive immunotherapy of glioblastoma.

Authors:  Alexia Ghazi; Aidin Ashoori; Patrick J Hanley; Vita S Brawley; Donald R Shaffer; Yvonne Kew; Suzanne Z Powell; Robert Grossman; Zakaria Grada; Michael E Scheurer; Meenakshi Hegde; Ann M Leen; Catherine M Bollard; Cliona M Rooney; Helen E Heslop; Stephen Gottschalk; Nabil Ahmed
Journal:  J Immunother       Date:  2012 Feb-Mar       Impact factor: 4.456

Review 5.  Systematic review of supportive care needs in patients with primary malignant brain tumors.

Authors:  Elizabeth Ford; Susan Catt; Anthony Chalmers; Lesley Fallowfield
Journal:  Neuro Oncol       Date:  2012-02-03       Impact factor: 12.300

6.  Vitamin D receptor expression is associated with improved overall survival in human glioblastoma multiforme.

Authors:  Débora G Salomón; María E Fermento; Norberto A Gandini; María J Ferronato; Julián Arévalo; Jorge Blasco; Nancy C Andrés; Jean C Zenklusen; Alejandro C Curino; María M Facchinetti
Journal:  J Neurooncol       Date:  2014-03-01       Impact factor: 4.130

7.  Dominant-negative inhibition of the Axl receptor tyrosine kinase suppresses brain tumor cell growth and invasion and prolongs survival.

Authors:  Peter Vajkoczy; Pjotr Knyazev; Andrea Kunkel; Hans-Holger Capelle; Sandra Behrndt; Hendrik von Tengg-Kobligk; Fabian Kiessling; Uta Eichelsbacher; Marco Essig; Tracy-Ann Read; Ralf Erber; Axel Ullrich
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-03       Impact factor: 11.205

8.  Characterizing the role of PCDH9 in the regulation of glioma cell apoptosis and invasion.

Authors:  Chunlin Wang; Bangbao Tao; Shiting Li; Bing Li; Xiaoqiang Wang; Guohan Hu; Weiqing Li; Yuhong Yu; Yicheng Lu; Jiachuan Liu
Journal:  J Mol Neurosci       Date:  2013-11-09       Impact factor: 3.444

9.  Overexpression of integrin-linked kinase (ILK) promotes glioma cell invasion and migration and down-regulates E-cadherin via the NF-κB pathway.

Authors:  Feng Liang; Shuqin Zhang; Bing Wang; Jianwu Qiu; Yunjie Wang
Journal:  J Mol Histol       Date:  2013-09-13       Impact factor: 2.611

10.  Extracranial oral cavity metastasis from glioblastoma multiforme: A case report.

Authors:  Philipp Günther Kup; Carsten Nieder; Guido Winnekendonk; Irenäus Anton Adamietz; Khashayar Fakhrian
Journal:  Mol Clin Oncol       Date:  2016-08-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.